{
    "eid": "2-s2.0-84975122062",
    "title": "Association of interferon-gamma inducible protein 10 polymorphism with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B",
    "cover-date": "2016-01-01",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        }
    ],
    "keywords": [],
    "authors": [
        "Umaporn Limothai"
    ],
    "citedby-count": 8,
    "ref-count": 40,
    "ref-list": [
        "Hepatitis B virus infection",
        "Management of hepatitis B: Summary of a clinical research workshop",
        "Effectiveness of hepatitis B treatment in clinical practice",
        "Review article: Genetic factors that modify the outcome of viral hepatitis",
        "Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance",
        "IL28B is associated with response to chronic hepatitis C interferon-\u03b1 and ribavirin therapy",
        "Genome-wide association of IL28B with response to pegylated interferon-\u03b1 and ribavirin therapy for chronic hepatitis C",
        "A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians",
        "Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B",
        "Effect of HLA-DP and IL28B gene polymorphisms on response to interferon treatment in hepatitis B e-antigen seropositive chronic hepatitis B patients",
        "Expression of IFN-lnducible protein-10 in chronic hepatitis",
        "IFN-\u03b3-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking",
        "Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C",
        "Association of pretreatment serum interferon \u03b3 inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C",
        "Response prediction in chronic hepatitis c by assessment of IP-10 and IL28B-related single nucleotide polymorphisms",
        "Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B",
        "Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy",
        "Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-\u03b3-induced protein 10 levels in HBV/HCV-coinfected patients",
        "Regulatory Polymorphisms in the Promoter of CXCL10 Gene and Disease Progression in Male Hepatitis B Virus Carriers",
        "Association of Interferon-gamma Induced Protein 10 Promoter Polymorphisms with the Disease Progression of Hepatitis B Virus Infection in Chinese Han Population",
        "EASL clinical practice guidelines: Management of chronic hepatitis B virus infection",
        "A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma",
        "Genetic association of human leukocyte antigens with chronicity or resolution of hepatitis B infection in Thai population",
        "IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6",
        "Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients",
        "Non invasive evaluation of portal hypertension using transient elastography",
        "Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues",
        "High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study",
        "Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients",
        "Decreasing Levels of HBsAg Predict HBsAg Seroclearance in Patients With Inactive Chronic Hepatitis B Virus Infection",
        "Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C",
        "Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV",
        "Hepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-\u03baB and increases migration of leukocytes",
        "Persistent hepatitis B viral replication in a FVB/N mouse model: Impact of host and viral factors",
        "Rapid downregulation of programmed death-1 and interferon-\u03b3-inducible protein-10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B",
        "Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B",
        "Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B",
        "IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-\u03b1",
        "IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients",
        "Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-\u03b1-2a therapy"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": []
}